Good MorningThe S&P 500 stood tall the day before the Independence Day holiday and set a new all-time high. The market broke above a critical resistance point and set itself up to continue higher in the second half. The technical targets suggest the S&P 500 will reach 6,100 by year's end, and a higher high may be reached. The market is being driven by tech and AI, and the second half's outlook includes broadening within the market. As it is, a few key players are reaping the rewards, but more are expected to participate in the boom as AI services expand.
The highlights of the second half of 2024 will include the FOMC. The FOMC is tracking for an interest rate cut by September and possibly two by the end of the year. The risk for bulls is that the Fed is unlikely to cut much or quickly because it risks accelerating inflation. In this light, the S&P 500 can continue to rally in 2024 but may hit a ceiling early next year. Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Consumer Staples | |
The Fourth of July is a cornerstone of American tradition that signifies a time for celebration, family gatherings, and festive cookouts. This holiday's cultural impact resonates deeply within the consumer landscape, often driving a surge in spending on goods and services in the consumer discretio... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Medical | |
In a holiday-shortened week, shares of AbbVie Inc. (NYSE: ABBV) are down a little more than 3%. To put that in context, the drop in ABBV stock was more than that of biotech stocks such as Johnson & Johnson (NYSE: JNJ), which is down 0.68%, and Pfizer Inc. (NYSE: PFE), which is down 1.38%.
... Read the Full Story |
|
Technology | |
That's right, the better stock to watch for those investors who value momentum over everything else in the technology sector is not actually NVIDIA Co. (NASDAQ: NVDA). Understanding that the artificial intelligence wave is only getting started, especially considering that chip and semiconductor te... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Technology | |
The market for GitLab (NASDAQ: GTLB) collapsed in late May when it announced high-severity flaws in its platform. The news was especially shocking coming from a DevSecOps platform, but the impact on the share price has been short-lived. The market is already rebounding from its lows and is likel... Read the Full Story |
|
Auto/Tires/Trucks | |
Despite sinking to an all-time low in April, shares of Rivian Automotive, Inc. (NASDAQ: RIVN) have been on a heater in recent weeks. The electric vehicle (EV) maker, considered one of the stronger alternatives to the king of EVs, Tesla Inc (NASDAQ: TSLA), has seen its shares gain more than 80% i... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Technology | |
Clarivate (NYSE: CLVT) may not be the cheapest AI stock worth buying, but it is inexpensive and set up to rebound strongly over the next few quarters. Trading at a mere 7.5x its earnings outlook for 2025, it is a super-deep value compared to leading AI plays, and the estimates for earnings growth ... Read the Full Story |
|
Markets | |
We recently carried out a survey among 3,000 business executives to identify which cities they consider hidden gems for launching a startup. The results are below.
Key Findings & Implications
Overall:
Regional Clusters: Many hidden gem cities are clustered in regions known for their str... Read the Full Story |
|
Markets | | A significant short interest may result in a squeeze, but what do the prominent short positions represent? Understanding the implications of high short interest, including the potential for significant price volatility and the underlying health of companies, is essential for retail traders.
What is... Read the Full Story |
|
Energy | |
Most of the market attention remains with the technology sector today, where all of 2024 has been centered around every stock related to artificial intelligence, particularly those in the chip and semiconductor space. When reading this, most investors probably thought of NVIDIA Co. (NASDAQ: NVDA) ... Read the Full Story |
|
Industrials | |
Generac Holdings Inc. (NYSE: GNRC) has long been synonymous with backup power generation, holding a commanding presence in a market driven by the need for energy reliability. However, recent developments have created a complex narrative, leaving investors to decipher a mixture of positive and co... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California. | | View Today's Stock Pick |
|
